Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats

Diabetes

Volumn 50, Issue 12, 2001, Pages 2815-2821

  Cheng, Juei Tang ^a   Liu, I Min ^a   Chi, Tzong Cherng ^a   Tzeng, Thing Fong ^b   Lu, Feng Hwa ^a   Chang, Chih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLUCOSE; GLUCOSE TRANSPORTER; GLUT 4 PROTEIN; GLUT-4 PROTEIN; GLYCOGEN; MESSENGER RNA; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRAMADOL;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LIVER; MALE; METABOLISM; PHYSIOLOGY; RAT; RAT STRAIN; SKELETAL MUSCLE;

ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCONEOGENESIS; GLUCOSE; GLYCOGEN; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; KINETICS; LIVER; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE, SKELETAL; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRAMADOL;

EID: 0035650637     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2815     Document Type: Article

References (31)

1. Curry DL, Li CH: Stimulation of insulin secretion by beta-endorphin (1-27 & 1-31). Life Sci 40:2053-2058, 1987
2. Feldberg W, Smyth DG: C-fragment of lipotropin - an endogenous potent analgesic peptide. Br J Pharmacol 60:445-453, 1977
3. Pfeiffer A, Feuerstein G, Zerbe RL, Faden AJ, Kopin IJ: Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology 113:929-933, 1983
4. Locatelli A, Spotti D, Caviezel F: The regulation of insulin and glucagon secretion by opiates: a study with naloxone in healthy humans. Acta Diabetol Lat 22:25-31, 1985
5. Khawaja XZ, Green IC, Thorpe JR, Titheradge MA: The occurrence and receptor specificity of endogenous opioid peptides with pancreas and liver of the rat: comparison with brain. Biochem J 267:233-240, 1990
6. Liu IM, Niu CS, Chi TC, Kuo DH, Cheng JT: Investigations of the mechanism of the reduction of plasma glucose by cold-stress in streptozotocin-induced diabetic rats. Neurosci 92:1137-1142, 1999
7. Liu IM, Chi TC, Chen YC, Lu FH, Cheng JT: Activation of opioid μ-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett 265:183-186, 1999
8. Lehmann KA: Tramadol for the management of acute pain. Drugs 47:19-32, 1994
9. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL: Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exper Ther 260:275-285, 1992
10. Vickers MD, O'Flaherty D, Szekely SM, Read M, Yoshizumi J: Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 47:291-296, 1992
11. Miranda HF, Pinardi G: Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 61:357-360, 1998
12. Pessin JE, Bell GI: Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 54:911-930, 1992
13. Hanson RW, Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611, 1997
14. Cheng JT, Shen CL, Huang JJ: Decrease of catecholamine and neuropeptide Y-like immunoreactivity in the glycerol-induced acute renal failure of rats. Res Exp Med 190:315-322, 1990
15. Yamada J, Sugimoto Y, Kiyo I: Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol 3852:211-215, 1999
16. Chang SL, Lin JG, Chi TC, Liu I, Cheng JT: An insulin-dependent hypoglycemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia 42:250-255, 1999
17. Liu IM, Hsu FL, Chen CF, Cheng JT: Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br J Pharmacol 129:631-636, 2000
18. Turinsky J, Nagel GW, Elmendorf JS, Damrau-Abney A, Smith TR: Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem J 313:215-222, 1996
19. Fry JR, Jones CA, Wiebkin P, Bellemann P, Bridges JW: The enzymic isolation of adult rat hepatocytes in a functional and viable state. Analyt Biochem 71:341-350, 1976
20. Agius L, Peak M, Alberti KG: Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem J 266:91-102, 1990
21. Martin WR: Opioid antagonists. Pharmacol Rev 19:463-521, 1967
22. Ling GSF, Simantov R, Clark JA, Pasternak GW: Naloxonazine actions in vivo. Eur J Pharmacol 129:33-38, 1986
23. Halfpenny DM, Callado LF, Hopwood SE, Bamigbade TA, Langford RM, Stamford JA: Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real tune voltammetry. Br J Anaesth 83:909-915, 1999
24. 2B/2C receptors. Eur J Pharmacol 359:185-190, 1998
25. Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat: effects of insulin treatment. Diabetes 36:1014-1018, 1987
26. Ziel FH, Venkatesan N, Davidson MB: Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37:885-890, 1988
27. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyl L, Permutt MA, Holloszy JO: Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 259: E593-E598, 1990
28. Bollen M, Keppens S, Stalmans W: Specific features of glycogen metabolism in the liver. Biochem J 336:1-31, 1998
29. Consoli A, Nurjhan N, Capani F, Gericht J: Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557, 1989
30. Chaturvedi K, Shahrestanifar M, Howells RD: mu Opioid receptor role for the amino terminus as a determinant of ligand binding affinity. Brain Res Mol Brain Res 76:64-72, 2000
31. Greenwald MK, Stitzer ML, Haberny KA: Human pharmacology of the opioid neuropeptide dynorphin A(1-13). J Pharmacol Exp Ther 281:1154-1163, 1997